The effect of competitive and noncompetitive NMDA receptor antagonists, ACPC and MK-801 on NPY and CRF-like immunoreactivity in the rat brain amygdala

Neuropeptides

Volumn 35, Issue 5-6, 2001, Pages 219-226

  Wieronska J M ^a   Branski P ^a   Palvcha A ^a   Smialowska M ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

1 AMINOCYCLOPROPANECARBOXYLIC ACID; CORTICOTROPIN RELEASING FACTOR; DIZOCILPINE; GLUTAMIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEUROPEPTIDE Y; 1-AMINOCYCLOPROPANE-1-CARBOXYLIC ACID; AMINO ACID; DIZOCILPINE MALEATE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROPROTECTIVE AGENT;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANXIETY; ARTICLE; BEHAVIOR; CONTROLLED STUDY; FEAR; IMMUNOHISTOCHEMISTRY; MALE; NERVE ENDING; NEUROTRANSMISSION; NONHUMAN; PERIKARYON; PRIORITY JOURNAL; RAT; ANIMAL; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; METABOLISM; NERVE CELL; WISTAR RAT;

AMINO ACIDS, CYCLIC; AMYGDALA; ANIMALS; ANXIETY; CORTICOTROPIN-RELEASING HORMONE; DIZOCILPINE MALEATE; MALE; NEURONS; NEUROPEPTIDE Y; NEUROPROTECTIVE AGENTS; RATS; RATS, WISTAR; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 0035545170     PISSN: 01434179     EISSN: None     Source Type: Journal    
DOI: 10.1054/npep.2002.0874     Document Type: Article

References (48)

1. Plasma and platelet excitatory amino acids in psychiatric disorders
2. Dopaminergic agonists normalize elevated hypothalamic neuropeptide Y and corticotropin-releasing hormone, body weight gain, and hyperglycemia in ob/ob mice
3. Neuropeptide Y blocks anxiogenic-like behavioral action of corticotropin-releasing factor in an operant conflict test and elevated plus maze
4. Interactions between glutamatergic and monoaminergic systems within the basal ganglia-implications for schizophrenia and Parkinson's disease
5. Interfering with glutamatergic neurotransmission by means of NMDA antagonist administration discloses the locomotor stimulatory potential of other transmitter systems
6. The anatomy of neuropeptide-Y-containing neurons in the rat brain
7. N-methyl-D-aspartate (NMDA)-mediated corticotropin-releasing factor (CRF) release in cultured rat amygdala neurons
8. The role of amygdala in conditioned fear
9. Neurotransmission in the rat amygdala related to fear and anxiety
10. Corticotropin-releasing factor has an anxiogenic action in the social interaction test
11. Biosynthesis of corticotropin-releasing hormone in human T-lymphocytes
12. Differential localization of NMDA and AMPA receptor subunits in the lateral and basal nuclei of the amygdala: A light and electron microscopic study
13. Hypothalamic norepinephrine depletion inhibits CRF-41 release following neural stimuli
14. Immunohistochemical alterations in neuropeptide Y-positive nerve elements in rat cerebral cortex following acute phencyklidine treatment
15. The effects of acute phencyclidine treatment on neuropeptide Y (NPY) neuronal system in the rat arcuate nucleus studied by immunocytochemistry and in situ hybridization
16. Role of the amygdala and periaqueductal gray in anxiety and panic
17. Neuropeptide Y localization in the rat amygdaloid complex
18. Centrally administered neuropeptide Y (NPY) produces anxiolytic-like effects in animal anxiety models
19. Anxiolytic-like effect of neuropeptide Y (NPY), but not other peptides in an operant conflict test
20. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabelled antibody (PAP) procedures
21. Alpha-helical CRF(9-41) prevents anxiogenic-like effect of NPY Y1 receptor antagonist BIBP3226 in rats
22. NMDA receptor complex antagonists have potential anxiolytic effects as measured with separation-induced ultrasonic vocalizations
23. Striatal neuropeptide Y are under the influence of the nigrostriatal dopaminergic pathway: Immunohistochemical evidence
24. Diazepam and buspirone alter neuropeptide Y-like immunoreactivity in rat brain
25. NMDA agonists and antagonists as probes of glutamatergic dysfunction and pharmacotherapies in neuropsychiatric disorders
26. Hippocampal CRF, NE, and NMDA system interactions in memory processing in the rat
27. Differential increases in brain levels of neuropeptide Y and vasoactive intestinal polypeptide after kainic acid-induced seizures in the rat
28. Characterization of phencyclidine-induced effects on neuropeptide Y systems in the rat caudate-putamen
29. Dynamic dopaminergic regulation of neuropeptide Y systems in discrete striatal and accumbens regions
30. The effects of alprazolam on corticotropin-realising factor neurons in the rat brain: Implications for a role for CRF in the pathogenesis of anxiety disorders
31. Acute effects of alprazolam and adinazolam on the concentrations of corticotropin-realising factor in the rat brain
32. Central and feedback regulation of hypothalamic corticotropin-releasing factor secretion
33. Effects of antagonists at the NMDA receptor complex in two animal models of anxiety
34. Anticonflict effects of a competitive NMDA receptor antagonist and a partial agonist at strychnine-insensitive glycine receptors
35. Anxiolytic-and antidepressant-like effects of an antagonist at glycineB receptors
36. Distribution and efferent projections of corticotropin-realising factor-like immunoreactivity in the rat amygdaloid complex
37. Amygdalar neuropeptide Y Y1 receptors mediate the anxiolytic-like actions of neuropeptide Y in the social interaction test
38. Expression of neuropeptide Y immunoreactivity in the rat nucleus accumbens is under the influence of the dopaminergic mesencephalic pathway
39. Reversal of the adaptive response of neuropeptide Y neurons in the rat striatum to nigrostriatal dopamine deafferentation by the N-methyl-D-aspartate antagonist dizocilpine maleate
40. Evaluation of glutamate as a neurotransmitter of cerebellar parallel fibers
41. Chronic administration of the triazolobenzodiazepine alprazolam produces opposite effects on corticotropin-realising factor and urocortin neuronal systems
42. An inhibitory dopaminergic regulation of the neuropeptide Y immunoreactivity expression in the rat cerebral cortex neurons
43. Activation of metabotropic glutamate receptors increases neuropeptide Y expression in the rat hippocampus. Immunohistochemical studies
44. Effects of 6-hydroxydopamine on neuropeptide Y and corticotropin-releasing factor expression in rat amygdala
45. Haloperidol-induced increase in neuropeptide Y immunoreactivity in locus coeruleus of the rat brain
46. Suppressed neuropeptide Y (NPY) mRNA in rat amygdala following restraint stress
47. Behavioral pharmacology of N-methyl-D-aspartate antagonists: Implications for the study and pharmacotherapy of anxiety and schizophrenia